BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12950155)

  • 1. Malignancy risk in patient with neurofibromatosis and autosomal dominant polycystic kidney disease.
    Flego V; Radojcić Badovinac A; Plese V; Kapović M; Beg-Zec Z; Zaputović L
    Croat Med J; 2003 Aug; 44(4):485-8. PubMed ID: 12950155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of autosomal dominant polycystic kidney disease and neurofibromatosis: report of a family.
    Chen MH; Chen KS; Hou JW; Lee CC; Huang JS
    Am J Nephrol; 2002; 22(4):376-80. PubMed ID: 12169872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gene diagnosis of autosomal dominant polycystic kidney disease type 2 using microsatellite DNA tightly linked to polycystic kidney disease gene 2].
    Zhang WL; Zhang DY; Wu YM; Sun TM; Mei CL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):325-8. PubMed ID: 15300626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years.
    Dicks E; Ravani P; Langman D; Davidson WS; Pei Y; Parfrey PS
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):710-7. PubMed ID: 17699277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of uromodulin and SAH genes, positional candidates for autosomal dominant medullary cystic kidney disease linked to 16p12.
    Casari G; Amoroso A
    J Nephrol; 2003; 16(3):459. PubMed ID: 12839032
    [No Abstract]   [Full Text] [Related]  

  • 6. [Autosomal-dominant polycystic kidney disease].
    Fick G; Weber M
    Dtsch Med Wochenschr; 1992 Jul; 117(30):1160-4. PubMed ID: 1633764
    [No Abstract]   [Full Text] [Related]  

  • 7. Exclusion of the neurofibromatosis 1 locus in a family with inherited café-au-lait spots.
    Brunner HG; Hulsebos T; Steijlen PM; der Kinderen DJ; vd Steen A; Hamel BC
    Am J Med Genet; 1993 Jun; 46(4):472-4. PubMed ID: 8357027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic approach in autosomal dominant polycystic kidney disease.
    Pei Y
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1108-14. PubMed ID: 17699332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal dominant polycystic kidney disease presenting with hepatic encephalopathy.
    Alkali M; Hamidu AU; Modu A
    Ann Afr Med; 2009; 8(2):136-8. PubMed ID: 19805947
    [No Abstract]   [Full Text] [Related]  

  • 10. The genetic role in autosomal dominant polycystic kidney disease and nephrology clinical practice.
    Avery-Lynch M
    CANNT J; 2004; 14(4):26-9, 32-5; quiz 29-30, 35-6. PubMed ID: 15673153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic kidney disease in Hajdu-Cheney syndrome.
    Kaplan P; Ramos F; Zackai EH; Bellah RD; Kaplan BS
    Am J Med Genet; 1995 Mar; 56(1):25-30. PubMed ID: 7747781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE gene I/D polymorphism and the presence of renal failure or hypertension in autosomal dominant polycystic kidney disease (ADPKD).
    Gumprecht J; Zychma MJ; Karasek D; Grzeszczak W
    Nephrol Dial Transplant; 2007 May; 22(5):1483. PubMed ID: 17205958
    [No Abstract]   [Full Text] [Related]  

  • 13. Earlier diagnosis of autosomal dominant polycystic kidney disease: importance of family history and implications for cardiovascular and renal complications.
    Taylor M; Johnson AM; Tison M; Fain P; Schrier RW
    Am J Kidney Dis; 2005 Sep; 46(3):415-23. PubMed ID: 16129202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal dominant polycystic kidney disease reduces the risk of diabetes mellitus.
    Pietrzak-Nowacka M; Rózanski J; Safranow K; Kedzierska K; Dutkiewicz G; Ciechanowski K
    Arch Med Res; 2006 Apr; 37(3):360-4. PubMed ID: 16513485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease.
    Paterson AD; Magistroni R; He N; Wang K; Johnson A; Fain PR; Dicks E; Parfrey P; St George-Hyslop P; Pei Y
    J Am Soc Nephrol; 2005 Mar; 16(3):755-62. PubMed ID: 15677307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polycystic kidney diseases: molecular genetics and counselling].
    Lespinasse J; Fourcade J; Schir F
    Nephrol Ther; 2006 Jul; 2(3):120-6. PubMed ID: 16890136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular genetics of autosomal dominant polycystic kidney disease.
    Reeders ST; Germino GG
    Semin Nephrol; 1989 Jun; 9(2):122-34. PubMed ID: 2672220
    [No Abstract]   [Full Text] [Related]  

  • 18. Ureteropelvic junction obstruction in association with autosomal dominant polycystic kidney disease: a case report in a trauma patient.
    Zaslau S; Talug C; Boo S; Roberts L
    W V Med J; 2008; 104(1):15-7. PubMed ID: 18335780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease.
    Drenth JP; Tahvanainen E; te Morsche RH; Tahvanainen P; Kääriäinen H; Höckerstedt K; van de Kamp JM; Breuning MH; Jansen JB
    Hepatology; 2004 Apr; 39(4):924-31. PubMed ID: 15057895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal-dominant polycystic kidney disease.
    Zeltner R; Hilgers KF; Schmieder RE; Porst M; Schulze BD; Hartner A
    Nephron Clin Pract; 2008; 108(3):c169-75. PubMed ID: 18277079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.